Lakeside Holding Ltd

LSH

Explore Our Financial Data > Companies > Lakeside Holding Ltd

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	LSH
CIK	0001996192
SIC	4731
Sector	Transportation, Communications, Electric, Gas, And Sanitary Services
Industry Category	Transportation
Industry Group	Arrangement Of Transportation Of Freight And Cargo

Contact

Address	1475 THORNDALE AVE SUITE A, ITASCA, IL, 60143
Website	www.americanbearlogistics.com
Phone	(312) 709-8450
CEO	Henry Liu
Employees	N/A

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$16.93 million
Pre-Tax Income	$-3.24 million
Net Income	$-3.27 million
Net Income to Common	$-3.27 million
EPS	N/A

View All

Balance Sheet

Cash	$1.12 million
Assets	$9.84 million
Liabilities	$8.19 million
Common Equity	$1.65 million
Liabilities & Equity	$9.84 million

View All

Cash Flow Statement

Net Income	$-3.27 million
Cash From Operating Activities	$-2.24 million
Cash From Investing Activities	$-1.35 million
Cash From Financing Activities	$4.39 million
Change in Cash	$782,681.00

View All

Calculations

NOPAT	$-2.45 million
EBITDA	$-2.86 million
Price to Earnings	N/A
Price to Book	N/A
ROE	-198.47%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION

Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd., today announced that it has entered into a securities purchase agreement with an institutional investor for the sale of senior secured 7% original issue discount convertible promissory notes ( "Notes") in the pr

Article Link

Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results

Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd., today announced financial results for its fiscal 2025 second quarter and first half ended December 31, 2024.

Article Link

Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical

Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that its wholly owned subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd. ("Hupan Pharmaceutical"), has entered into two distribution agreements with Hubei Kelun Pharmaceutical Trading Co., Ltd., a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd., a publicly traded company on the Shenzhen Stock Exch

Article Link

Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution

Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market today announced that Hupan Pharmaceutical has entered into a strategic distribution agreement with Sichuan Huiyu Pharmaceutical Co., Ltd. ("Huiyu Pharmaceutical").

Article Link

Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary

Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that Hupan Pharmaceutical has signed a Sales Agreement (the "Agreement") with Sinopharm Holding Hubei New Special Medicine Co., Ltd. ("Sinopharm Hubei"), a subsidiary of Sinopharm Group. The Agreement, valued at approximately RMB 11.0 million (approximately $1.5 million), is effective from January 1, 2

Article Link